Internal validity of clinical trials for Plasmodium vivax malaria treatment;Validade interna de ensaios terapêuticos em malária: Análise de estudos de avaliação da emergência de resistência in vivo do Plasmodium vivax a doses padronizadas de primaquina

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 3, 2003, Pages 383-386

  Duarte, Elisabeth Carmen ^a,c   Pang, Lorrin ^c   Fernandes Fontes, Cor Jesus ^a,b  

^a Nucl Estud Doen Infecc T M G   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c Jardim Petrópolis ^*

Author keywords

In vivo resistance; Internal validity; Plasmodium vivax; Primaquine

Indexed keywords

PRIMAQUINE;

ARTICLE; CLINICAL RESEARCH; HEALTH SERVICE; HUMAN; INFECTION CONTROL; MALARIA; MEDICAL RECORD; PLASMODIUM VIVAX; TREATMENT FAILURE; VALIDATION PROCESS;

PLASMODIUM VIVAX;

EID: 0037817702     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822003000300011     Document Type: Article

References (13)

1. Arias AE, Corredor A. Low response of Colombian strains of Plasmodium vivax to antimalarial therapy. Tropical Medicine and Parasitology 40:21-23, 1989.
2. Benenson AS. Control of communicable disease in man 16th ed, Pan American Health Organization, Washington, 1995.
3. Collins WE, Jeffery GM. Primaquine resistance in Plasmodium vivax. American Journal of Tropical Medicine and Hygiene 55:243-249, 1996.
4. Duarte EC, Pang LW, Corrêa Ribeiro L, Fontes CJF. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. American Journal of Tropical Medicine and Hygiene 65: 471-476, 2001.
5. Durlacher RR, Cerutti-Junior C, Alencar FEC, Ogando SLA, Arruk VG, Avila SLM, Duarte EC, Pang LW, Ferreira AW. Avaliação da resposta imune humoral em pacientes com malária por Plasmodium falciparum submetidos à terapêutica com quinina e mefloquina. Revista da Sociedade Brasileira de Medicina Tropical 32;195-197, 1999.
6. Fundaçao Nacional de Saúde. Doenças infecciosas e parasitárias. Aspectos clínicos, vigilância epidemiológica e medidas de controle. FUNASA-MS, Ministério da Saúde, Brasilia, 1999.
7. Na DJ, Han JD, Cha DY, Song IK, Choi HW, Chung EA, Park CW, Choi JS. Imported tertian malaria resistant to primaquine. Korean Journal of Internal Medicine 14:86-89, 1999.
8. Nayar JK, Baker ARH, Knight JW, Sullivan JS, Morris CL, Richardson BB, Galland GG, Collins WE. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. Journal of Parasitology 83:739-745, 1997.
9. Petralanda I. Quality of antimalarial drugs and resistance to Plasmodium vivaxin Amazonian region. The Lancet 345: 1433, 1995.
10. Tan-ariya P, Na-Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J. Clinical response and susceptibility in vitro of Plasmodium vivaxto standard regimen of chloroquine in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 89:426-429, 1995.
11. White NJ. Why is it that antimalarial drug treatments do not always work? Annals of Tropical Medicine and Parasitology 92:449-458, 1998.
12. World Health Organization. Resistance of malaria parasites to drugs. World Health Organ Tech Rep Ser 529, 1965.
13. Yi KJ, Chung MH, Kim HS, Kim CS, Pai SH. A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy. Korean Journal of Parasitology 36:143-146, 1998.